LOH analysis of free DNA in the plasma of patients with mucosal malignant melanoma in the head and neck

International Journal of Clinical Oncology

Volumn 12, Issue 3, 2007, Pages 199-204

  Takagi, Ryo ^a   Nakamoto, Daisuke ^a,b   Mizoe, Jun Etsu ^a   Tsujii, Hirohiko ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Charged particle therapy; Free DNA; Loss of heterozygosity; Mucosal malignant melanoma

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DNA DETERMINATION; EARLY DIAGNOSIS; FEMALE; GENE LOCUS; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; ION THERAPY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MICROSATELLITE MARKER; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT FAILURE; TUMOR VOLUME;

AGED; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MICROSATELLITE REPEATS; MIDDLE AGED; NOSE NEOPLASMS; PHARYNGEAL NEOPLASMS; PROGNOSIS; RESPIRATORY MUCOSA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34250689160     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0650-x     Document Type: Article

References (24)

1. Japanese Skin Cancer Society Prognosis and Statistical Investigation Committee 2000 Questionnaire of a malignant melanoma in Japan (in Japanese) Skin Cancer 15 7 14
2. SA Leon B Shapiro DM Sklaroff 1997 Free DNA in the serum of cancer patients and the effect of therapy Cancer Res 37 646 650
3. B Shapiro M Chakrabarty EM Cohn 1983 Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease Cancer 51 2116 2120
4. JM Silva G Dominguez JM Garcia 1999 Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations Cancer Res 59 3251 3256
5. JM Silva J Silva A Sanchez 2002 Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival Clin Cancer Res 8 3761 3766
6. B Taback SJ O'Day DS Hoon 2004 Quantification of circulating DNA in the plasma and serum of cancer patients Ann N Y Acad Sci 1022 17 24
7. X Chen H Bonnefoi S Diebold-Berger 1999 Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer Clin Cancer Res 5 2297 2303
8. G Sozzi K Musso C Ratcliffe 1999 Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis Clin Cancer Res 5 2689 2692
9. M Esteller M Sanchez-Cespedes R Rosell 1999 Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Res 59 67 70
10. DN Nunes LP Kowalski AJ Simpson 1999 Circulating tumor-derived DNA may permit the early diagnosis of head and neck squamous cell carcinomas Int J Cancer 92 214 219
11. H Nawroz W Koch P Anker 1996 Microsatellite alterations in serum DNA of head and neck cancer patients Nat Med 2 1035 1037
12. M Utting W Werner R Dahse 2002 Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer Clin Cancer Res 8 35 40
13. B Taback Y Fujiwara HJ Wang 2001 Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients Cancer Res 61 5723 5726
14. T Nakayama B Taback DH Nguyen 2000 Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients Ann N Y Acad Sci 906 87 98
15. F Shirasaki M Takata N Hatta 2001 Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23 Cancer Res 61 7422 7425
16. Y Fujiwara DD Chi H Wang 1999 Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients Cancer Res 59 1567 1571
17. EK Goldberg JM Glendening Z Karanjawala 2000 Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis Am J Hum Genet 67 417 431
18. RA Herbst R Gutzmer F Matiaske 1999 Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma Int J Cancer 80 205 209
19. G Palmieri A Cossu PA Ascierto 2000 Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases Br J Cancer 83 1707 1714
20. A Ruiz S Puig M Lynch 1998 Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma Int J Cancer 76 312 316
21. J Smeds R Kumar BL Rozell 2000 Increased frequency of LOH on chromosome 9 in sporadic primary melanomas is associated with increased patient age at diagnosis Mutagenesis 15 257 260
22. GJ Walker JM Palmer MK Walters 1995 A genetic model of melanoma tumorigenesis based on allelic losses Genes Chromosomes Cancer 12 134 141
23. FB Dean S Hosono L Fang 2002 Comprehensive human genome amplification using multiple displacement amplification Proc Natl Acad Sci USA 99 5261 5266
24. Y Lu L Gioia-Patricola JV Gomez 2005 Use of whole genome amplification to rescue DNA from plasma samples BioTechniques 39 511 515